ARFI elastography for the prediction of chemotherapeutic response in the patient with metastatic liver lesions

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000287

Enrollment

Registered

2011-12-12

Start date

2009-12-24

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : total 6 times Ultrasonography

before chemotherapy, 48Hr after chemotherapy starting, 1week, 2week, 3week,4week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Being diagnosed as liver metastasis newly, planned chemotherapy for the first time or changed other chemotheraphy 2. tumor should be measurable by CT or MR 3. tumor should be measurable by ARFI elastography

Exclusion criteria

Exclusion criteria: 1. not cooperative 2. the presence of ascites 3. difficulty in communication

Design outcomes

Primary

Measure	Time frame
The difference of ARFI average values between response and nonresponse group after chemotherapy	—

Secondary

Measure	Time frame
The time when the difference of ARFI value between response and nonresponse group becomes statistically significant.	—

Countries

Korea, Republic of

Contacts

Public ContactSoo Yeoun Kang

Seoul National University Hospital

Outcome results